Abstract:MicroRNAs (miRNAs) are a class of noncoding RNAs and function as key regulators of gene expression at the post-transcriptional level. In this study, we found that miR-495 reduces cell growth, induces apoptosis and suppresses the migration of endometrial cancer by directly inhibiting FOXC1 expression. Further analysis revealed that FOXC1 promotes growth and migration and functions as an oncogene in vitro. FOXC1 overexpression reversed the cellular responses mediated by miR-495 in endometrial cancer cells. We also found that miR-495 suppresses the growth of endometrial cancer in vivo. Altogether, these results indicate that miR-495 acts as a tumour suppressor gene by targeting FOXC1 at the post-transcriptional level in endometrial cancer.

Supplementary Figure Legends 1-2 from Definition of Micrornas That Repress Expression of the Tumor Suppressor Gene <i>foxo1</i> in Endometrial Cancer

Supplementary Figure 2 from Definition of Micrornas That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer

Supplementary Figure 1 from Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene <i>FOXO1</i> in Endometrial Cancer

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figure Legends from Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer Via Activation of Mir-126-5p/β-catenin/cbp Signaling

Supplementary Figure Legends 1-2 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

Supplementary Figures 1-6 from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legend from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Figure Legends from Mir-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma

Supplementary Figures 1-6 from The <i>miR-17-92</i> Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Supplementary Figure Legends 1-3 from MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity

Supplementary Table and Figure Legends from FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive Mir-342 in Human Colorectal Cancer

Supplementary Figure 6 from Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor

Supplementary Figure Legends from Plasma MicroRNAs As Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer

Supplementary Figure Legend from FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis Via Upregulation of Expression of the Urokinase Plasminogen Activator System

Supplementary Figure 7 from Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer Via Suppression of the FOXO1 Transcription Factor

Supplementary Figure Legends from Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype

Supplementary Tables from Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer

Supplementary Figure Legends 1-2 from Definition of Micrornas That Repress Expression of the Tumor Suppressor Gene &lt;i&gt;foxo1&lt;/i&gt; in Endometrial Cancer